Search results for #GenomicMedicines
💬 In one week our CMO Daniel Chung, DO, MA will be in Basel 🇨🇭 for the BioPharma Clinical Trials Nexus where he will be participating in 3 panel discussions. Watch below for more details on the panels ⬇️ nexus-conference.com/ctneu/ #GenomicMedicines #Ophthalmology #ClinicalTrials
That’s a wrap on the the 7th Annual Gene Therapy for Rare Disorders Summit Conference in Boston! 🎉 We return energized from having the opportunity to share our pioneering approach in ocular gene therapy with key industry experts💥 #genetherapy #genomicmedicines
💡 Next week, our team will be busy in Boston for the 7th Annual Gene Therapy for Rare Disorders Summit. Be sure to catch our CMO, Daniel C. Chung, DO, MA, at the sessions shown below! ⬇️ genetherapy-conference.com/?utm_source=di… #GenomicMedicines #Ophthalmology #GeneTherapy #GenomeEditing
👁️ #SaveYourVision Month may be coming to an end, but we’re still working hard developing genomic medicines and bring relief to inherited retinal disease (#IRD) patients 🧬 ➡️ Learn more here: sparingvision.com #GenomicMedicines #Ophthalmology #GeneTherapy #GenomeEditing
🌟 Later this month we’ll be in Boston for the Gene Therapy for Rare Disorders Summit between 26-27 March! We’re looking forward to meeting other industry leaders there! 💪 #GenomicMedicines #Ophthalmology #GeneTherapy #GenomeEditing
🇺🇸 Today is the start of #SaveYourVision Month in the US, an initiative dedicated to promoting the significance of regular eye check-ups to detect ocular diseases early, including retinitis pigmentosa (#RP) and age-related macular degeneration. 📣 #GenomicMedicines #GeneTherapy
💡 Don’t miss our CEO @BoisselStephane’s presentation at the #EvercoreISI 2024 Emerging Biotech Conference tomorrow at 9:35am ET/3:35pm CET. Learn how we’re pioneering genomics to save sight! 👁️🧬 #GenomicMedicines #Ophthalmology #GeneTherapy #GenomeEditing
Thanks for having us, California! 🏄 #ICYMI 🌟 Earlier this month, we presented clinical data for #SPVN06 for the first time at the Macula Society 47thAnnual Meeting held in Palm Springs. 👁️ Read the full release here: sparingvision.com/sparingvision-… #GenomicMedicines #GeneTherapy
📣 February is Age-Related Macular Degeneration (#AMD) and Low Vision Awareness Month! 👉 Find out more from @PBA_savingsight here: preventblindness.org/2024-amd-low-v… #GenomicMedicines #Ophthalmology #GeneTherapy #GenomeEditing
🌟 Today @BoisselStephane will attend the 2024 HYBRID Congress to discuss the challenges of #GenomeEditing approaches and how SparingVision is pioneering genomics to save sight. 👁️ Find out more here: hybridays.com #GenomicMedicines #Ophthalmology #GeneTherapy
💥 PRODYGY trial update! 👁️ We are delighted to announce a key advancement in our PRODYGY Phase I/II gene therapy trial of #SPVN06. sparingvision.com/sparingvision-… #Ophthalmology #GenomicMedicines #GeneTherapy #SPVN06 #Trial
We are excited to participate in the 12th edition of the virtual @degroofpetercam Healthcare Conference taking place from 23-26 January! 🙌 We look forward to meeting some of you virtually there! 😊 web.cvent.com/event/38fced4c… #GenomicMedicines #Ophthalmology #GeneTherapy
We’ve just wrapped up an amazing @jpmorgan Healthcare Conference in San Francisco! 🎉 Our team had a great time connecting with industry experts at the conference and at our own event over wine & cheese. #JPM2024 #GenomicMedicines #Ophthalmology #GeneTherapy #GenomeEditing
✨Happy Holidays from the team at SparingVision! ✨ We wish everyone a joyful end to 2023 spent with friends and family and we look forward to continuing our journey in the new year! 🌟 #HappyHolidays #GenomicMedicines #Ophthalmology #GeneTherapy
Before the end of the year, members of our French team joined our US team at our Philadelphia office to plan and prepare for the things to come in 2024. Things are looking exciting on our list and we’re looking forward to sharing updates with you. #GeneTherapy #GenomicMedicines
more #funding #news ~#ShinobiTherapeutics launches with $51M #SeriesA to advance #Hypoimmune #iPSTCellTherapy platform ~@BicaraTx announces #oversubscribed $165M #SeriesC #financing ~@Tome_bio launches with $213M in #funding, targets ‘New Era’ of #GenomicMedicines
🎉 Our co-founder, José-Alain Sahel, has today been named at the Elysée Palace as one of the 12 members of President @EmmanuelMacron's newly announced Presidential #ScienceCouncil 🏛️! Congratulations to José for this exciting new chapter! 🚀 #Innovation #GenomicMedicines
👁️🎁December is Gift of Sight Month! At SparingVision we are driven by a unified purpose, to eliminate blinding retinal disease. This month, let's join hands to spread the message of vision awareness and encourage regular eye check-ups 🌍 #GiftOfSightMonth #GenomicMedicines
We're excited to share the progress of our ophthalmology program at 2o Congreso Europeo Pacientes Mácula Retina by @macularetina , bringing hopes to patients suffering from #blindness or #visual #disabilities . #ceguera #discapacidad #biotecnologia #genetherapy #genomicmedicines
Since our 2021 launch, we’ve made great strides advancing our science and growing #TeamChroma! Thank you to our founders, investors, partners, and team for fueling our mission to advance a new class of #GenomicMedicines to revolutionize treatment of disease. #EpigeneticEditing